Oxytocin Add on Study for Stable Schizophrenic Patients
Status:
Terminated
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to compare the efficacy of intranasal oxytocin versus
intranasal placebo to improve symptoms in schizophrenia patients who have residual symptoms
despite being on adequate treatment with antipsychotic medication.